Severe Dyslipidemia Mimicking Familial Hypercholesterolemia Induced by High-Fat, Low-Carbohydrate Diets: A Critical Review

Nutrients. 2023 Feb 15;15(4):962. doi: 10.3390/nu15040962.

Abstract

Emerging studies in the literature describe an association between high-fat, low-carbohydrate diets and severe hypercholesterolemia consistent with the levels observed in patients with (homozygous) familial hypercholesterolemia (FH). High levels of low-density lipoprotein cholesterol (LDL-C) may result from the reduced clearance of LDL particles from the circulation, the increased production of their precursor, or a combination of both. The increased intake of (saturated) fat and cholesterol, combined with limited to no intake of carbohydrates and fiber, are the main features of diets linked to hypercholesterolemia. However, several observations in previous studies, together with our observations from our lipid clinic, do not provide a definitive pathophysiological explanation for severe hypercholesterolemia. Therefore, we review these findings and possible pathophysiological explanations as well as opportunities for future research. Altogether, clinicians should rule out high-fat, low-carbohydrate diets as a possible cause for hypercholesterolemia in patients presenting with clinical FH in whom no mutation is found and discuss dietary modifications to durably reduce LDL-C levels and cardiovascular disease risk.

Keywords: LDL cholesterol; cardiovascular disease; carnivore diet; familial hypercholesterolemia; high-fat diet; ketogenic diet; low-carbohydrate diet.

Publication types

  • Review

MeSH terms

  • Cholesterol
  • Cholesterol, LDL
  • Diet, Carbohydrate-Restricted
  • Dietary Carbohydrates
  • Dietary Fats
  • Dyslipidemias*
  • Fatty Acids
  • Humans
  • Hypercholesterolemia*
  • Hyperlipidemias*
  • Hyperlipoproteinemia Type II*

Substances

  • Cholesterol, LDL
  • Cholesterol
  • Fatty Acids
  • Dietary Carbohydrates
  • Dietary Fats

Grants and funding

This research was funded by research grants from the Netherlands Organization for Scientific Research (vidi 016.156.445) and Klinkerpad funds. VH is appointed by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Grant Agreement No. 813781 ITN BestTreat.